Ross, David M., Jeffrey J. Babon, Denis Tvorogov, and Daniel Thomas. 2021. ‚ÄúPersistence of Myelofibrosis Treated With Ruxolitinib: Biology and Clinical Implications‚ÄĚ. Haematologica 106 (5). Pavia, Italy, 1244-53. https://doi.org/10.3324/haematol.2020.262691.